Orphan Drugs Market by Product, Scope, Analysis and Forecasts to 2019
ReportsWeb.com published “Orphan Drugs Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, September 28, 2017 ) An orphan drug is used to treat rare diseases or disorders. According to WHO, orphan or rare diseases are the pathological conditions that affect 0.65-1 out of 10,000 population worldwide. There are around 6,000 orphan diseases, of which 80% are genetic. Orphan drugs are developed by the pharmaceutical industry to serve the public health need. These are designated as "Orphan Designations" by the regulatory agencies to accelerate the approval process.
Publisher's analysts forecast the global orphan drugs market to grow at a CAGR of 10.05% over the period 2014-2019.
For more information http://www.reportsweb.com/orphan-drugs-market-2015-2019
Covered in this report
The report covers the current scenario and the growth prospects of the global orphan drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales orphan drugs.
Publisher's report, Global Orphan Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and Europe; it also covers the landscape of the global orphan drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
- Americas
- APAC
- Europe
Key vendors
- Bristol-Mayer Squibb
- Celgene
- F. Hoffmann La Roche
- Novartis
- Pfizer
Request Sample Copy <||>rnhttp://www.reportsweb.com/inquiry&RW0001202030/sample
Other prominent vendors
- AbbVie
- Actelion Pharmaceuticals
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Amgen
- AstraZeneca
- Baxter International
- Biogen Idec
- Celldex Therapeutics
- Eisai
- Eli Lilly
- GlaxoSmithKline
- Intercept Pharmaceuticals
- Johnson & Johnson
- Merck
- NewLink Genetics
- Northwest Biotherapeutics
- Novo Nordisk
- Onyx Pharmaceuticals
- Sanofi
- Shire
- Synageva BioPharma
- Takeda
- Vertex Pharmaceuticals
- XOMA
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001202030/buying
Market driver
- Shorter development timelines
- For a full, detailed list, view our report
Market challenge
- High cost of drug development
- For a full, detailed list, view our report
Market trend
- Increased focus on biological drugs
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Purchase Report at http://www.reportsweb.com/buy&RW0001202030/buy/3000
Publisher's analysts forecast the global orphan drugs market to grow at a CAGR of 10.05% over the period 2014-2019.
For more information http://www.reportsweb.com/orphan-drugs-market-2015-2019
Covered in this report
The report covers the current scenario and the growth prospects of the global orphan drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales orphan drugs.
Publisher's report, Global Orphan Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and Europe; it also covers the landscape of the global orphan drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
- Americas
- APAC
- Europe
Key vendors
- Bristol-Mayer Squibb
- Celgene
- F. Hoffmann La Roche
- Novartis
- Pfizer
Request Sample Copy <||>rnhttp://www.reportsweb.com/inquiry&RW0001202030/sample
Other prominent vendors
- AbbVie
- Actelion Pharmaceuticals
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Amgen
- AstraZeneca
- Baxter International
- Biogen Idec
- Celldex Therapeutics
- Eisai
- Eli Lilly
- GlaxoSmithKline
- Intercept Pharmaceuticals
- Johnson & Johnson
- Merck
- NewLink Genetics
- Northwest Biotherapeutics
- Novo Nordisk
- Onyx Pharmaceuticals
- Sanofi
- Shire
- Synageva BioPharma
- Takeda
- Vertex Pharmaceuticals
- XOMA
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001202030/buying
Market driver
- Shorter development timelines
- For a full, detailed list, view our report
Market challenge
- High cost of drug development
- For a full, detailed list, view our report
Market trend
- Increased focus on biological drugs
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Purchase Report at http://www.reportsweb.com/buy&RW0001202030/buy/3000
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results